李进：Novel Vascular Endothelial Growth Factor Receptor Inhibitor YN968D1 (Apatinib） Against advanced Malignancies: Phase I/II Study
转载请注明来自丁香园
发布日期: 2009-10-17 10:12 文章来源: 丁香园
关键词: 李进 CSCO 点击次数：

 


李进：Novel Vascular Endothelial Growth Factor Receptor Inhibitor YN968D1 (Apatinib） Against advanced Malignancies: Phase I/II Study


李进：Novel Vascular Endothelial Growth Factor Receptor Inhibitor YN968D1 (Apatinib） Against advanced Malignancies: Phase I/II Study


李进：Novel Vascular Endothelial Growth Factor Receptor Inhibitor YN968D1 (Apatinib） Against advanced Malignancies: Phase I/II Study


李进：Novel Vascular Endothelial Growth Factor Receptor Inhibitor YN968D1 (Apatinib） Against advanced Malignancies: Phase I/II Study


李进：Novel Vascular Endothelial Growth Factor Receptor Inhibitor YN968D1 (Apatinib） Against advanced Malignancies: Phase I/II Study

< 上一页
分页: [1 ] 　 [2 ] 　 [3 ] 　 [4 ] 　 [5] 　

　　　作者: 丁香园通讯员


以下网友留言只代表网友个人观点，不代表网站观点



请输入验证码：